Back to search results

Support and Education for Hypersensitivity Pneumonitis

This study is testing two behavioral interventions for people with hypersensitivity pneumonitis (HP). One intervention, called RISE-HP, involves 10 weekly sessions with a peer coach (someone with HP experience) who provides support, education, and cognitive restructuring techniques. The other, "Staying Well," offers 12 weeks of educational sessions where you choose 10 topics to discuss with a research assistant. The main goal is to see if these programs can improve your health-related quality of life and how easy they are to use. You can join if you're 18 or older, have a diagnosed HP, speak English, have a smartphone and internet, and your doctor approves your participation. The study is currently unclear on its recruitment status and plans to enroll 42 participants.

Study design
This study is testing two different behavioral programs. It aims to enroll 42 participants.
What's involved
You would participate in either 10 weekly one-on-one meetings with a peer coach or 10 weekly educational sessions with a research coordinator, each lasting 30-45 minutes.
Compensation
Not stated in the trial record.
Follow-up
The study measures attrition, attendance, and retention rates for up to 10 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06811389

Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

Recruiting
NAAges 18+InterventionalSupportive care
Weill Medical College of Cornell University
~42 participants
Updated 2026-05-28 on ClinicalTrials.gov
What's tested:Re-imagining Interventions for Support and Education in Hypersensitivity Pneumonitis (RISE-HP)Staying Well

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Attrition Rate
Measured over up to 10 weeks
+3 more outcomes measured

Conditions

Hypersensitivity Pneumonitis

Explore related trials

Extrinsic Allergic Alveolitis

NCT06811389

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Weill Cornell Medicine

    New York, New Yorkstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Kerri I Aronson, MD · PRINCIPAL_INVESTIGATOR · Weill Medical College of Cornell University

Who to contact

Anna Tharakan, BS
[email protected]
(646)962-8130
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Have documented diagnosis of Hypersensitivity Pneumonitis by treating clinician.
Age 18 or older.
English Speaking.
Willing to work with a peer coach.
Have a working smart phone or tablet.
Have access to the internet.
Reside or live in the United States.
Endorse verbal approval from treating physician to participate in patients' goal movement/physical activity.
Meet one or more of the following criteria:
Baseline score on the PHQ8 of \<20

Exclusion

Does not have Hypersensitivity Pneumonitis
Younger than age 18
Severe cognitive impairment as determined by their treating physician.
Participants with severe depression (PHQ-8 score ≥20) will be ineligible for the study and will be referred to alternative sources of care.
Anyone with documentation in their medical chart of an eating disorder, active substance use disorder, suicidality, homicidality, acute posttraumatic stress disorder, or episodes of mania or psychosis.
Anyone who is determined to be severely ill or moribund by the treating clinician.

What this trial measures

  • Attrition Rateup to 10 weeks
  • Attendance rateup to 10 weeks
  • Retention rateup to 10 weeks
  • Implementation SurveyWeek 10

    Assesses feasibility and acceptability. A 5-point Likert scale written based on CFIR framework. The overall score will be calculated by adding individual scores for the items. Lower scores will indicate lower acceptability, appropriateness, or feasibility of the intervention and higher scores will indicate better acceptability, appropriateness, or feasibility of the intervention.